To ask the Secretary of State for Health and Social Care, when the NHS plans to make Paxlovid available for the treatment of covid-19; and under what eligibility criteria.
18 January 2022
We currently plan to deploy COVID-19 novel antivirals, including PF-07321332+ritonavir, co-packaged under the brand name Paxlovid, through the PANORAMIC national study. This will produce conclusive data on those would benefit most from antiviral treatments for COVID-19. We will provide an update in due course, including on whether any deployment outside the national study may take place.